LAM
RPRX icon

L2 Asset Management’s Royalty Pharma RPRX Stock Holding History

L2 Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.06M Buy
147,082
+1,328
+0.9% +$58.2K 0.67% 46
2025
Q4 		$5.63M Buy
145,754
+53,539
+58% +$2.04M 0.75% 45
2025
Q3 		$3.25M Buy
92,215
+85,459
+1,265% +$3.09M 0.47% 58
2025
Q2 		$243K Buy
+6,756
New +$224K 0.04% 315
2023
Q2 		– Sell
-67,057
Closed -$2.42M – 172
2023
Q1 		$2.42M Buy
67,057
+10,947
+20% +$406K 1.45% 20
2022
Q4 		$2.22M Sell
56,110
-1,689
-3% -$70.5K 1.43% 22
2022
Q3 		$2.32M Buy
+57,799
New +$2.47M 1.6% 18

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $95.1B AUM 30.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return